HomeIPHA • NASDAQ
Innate Pharma SA
add
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 3.89M | -63.74% |
Operating expense | 31.06M | 579.29% |
Net income | -12.35M | -166.01% |
Net profit margin | -317.73 | -633.62% |
Earnings per share | — | — |
EBITDA | -12.01M | -131.03% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 80.77M | -12.64% |
Total assets | 111.06M | -39.71% |
Total liabilities | 102.23M | -22.73% |
Total equity | 8.83M | — |
Shares outstanding | 81.33M | — |
Price to book | 17.64 | — |
Return on assets | -28.43% | — |
Return on capital | -79.28% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -12.35M | -166.01% |
Cash from operations | -4.97M | 52.91% |
Cash from investing | 4.13M | -60.40% |
Cash from financing | -840.50K | -133.47% |
Net change in cash | -1.80M | -344.80% |
Free cash flow | -9.92M | -253.84% |
Previous close
$1.94
Day range
$1.95 - $2.03
Year range
$1.29 - $3.51
Market cap
169.95M USD
Avg Volume
443.61K
About
Founded
1999
Website
Employees
168
